Search

everythinglearnresearchcommunity

for

Search:↓

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Hair loss in black women needs more research, early intervention, and community education.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Early shedding of the inner root sheath in noninflamed hair follicles is a relatively specific sign of Central Centrifugal Cicatricial Alopecia.

Black patients with a specific type of hair loss have a much higher chance of lacking enough vitamin D.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

CCCA may be caused by both hair traction and an immune response.

Topical metformin 10% cream may help treat central centrifugal cicatricial alopecia.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

Certain hairstyles, diabetes, scalp infections, and vitamin D deficiency may increase the risk of hair loss in Black women; more research is needed for better treatment.

Wearing a high-quality wig improved a woman's mood and life quality, and the authors suggest insurance should cover the cost of wigs.

More research is needed on CCCA in children, especially Black and Asian adolescents.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CCCA can affect both genders and all ages, and it has a genetic component.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

A scale was made to measure hair loss severity in African American women.

Using a special skin cream with gabapentin helped reduce symptoms of a certain scalp condition but didn't change nerve fibers or skin chemicals.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

A condition called Central Centrifugal Cicatricial Alopecia causes hair loss and scalp burning in middle-aged African women, and it's treated with various medications, hair transplants, and non-drug methods like wigs.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.